Literature DB >> 7995332

The pharmacokinetics of tiopronin as such is unknown.

M S Carlsson, T Denneberg, B M Emanuelsson, B Kågedal, S Lindgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7995332     DOI： 10.1007/BF00196122

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Pharmacokinetics of intravenous 2-mercaptopropionylglycine in man.

Authors:  S M Carlsson; T Denneberg; B M Emanuelsson; B Kågedal; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Changes in clearance create pharmacokinetic pitfalls as illustrated by studies on tiopronin.

Authors:  P A Sjöström
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  Determination of 2-mercaptopropionylglycine in plasma and urine by high-performance liquid chromatography.

Authors:  B Kågedal; M Carlsson; T Denneberg
Journal:  J Chromatogr       Date:  1986-08-02

5.  Pharmacokinetics of oral tiopronin.

Authors:  M S Carlsson; T Denneberg; B M Emanuelsson; B Kågedal; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  High-performance liquid chromatography of 2-mercaptopropionylglycine and its metabolite 2-mercaptopropionic acid in plasma and urine after treatment with thiopronine.

Authors:  B Kågedal; T Andersson; M Carlsson; T Denneberg; A Hoppe
Journal:  J Chromatogr       Date:  1987-07-03

7.  Alternative treatment of cystinuria with alpha-merkaptopropionylglycine, Thiola.

Authors:  T Denneberg; J O Jeppsson; P Stenberg
Journal:  Proc Eur Dial Transplant Assoc       Date:  1983
  7 in total
  2 in total

1.  Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria.

Authors:  Deepa A Malieckal; Frank Modersitzki; Kristin Mara; Felicity T Enders; John R Asplin; David S Goldfarb
Journal:  Urolithiasis       Date:  2019-04-13       Impact factor: 3.436

2.  Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jianhua Li; Xinguang Qiu; Wenzhi Guo; Bing Yan; Shuijun Zhang
Journal:  Med Oncol       Date:  2015-09-02       Impact factor: 3.064
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.